The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes.
 
Fergus Keane
No Relationships to Disclose
 
Drew Moss
No Relationships to Disclose
 
Catherine A O'Connor
No Relationships to Disclose
 
Maria Perry
No Relationships to Disclose
 
Joanne F. Chou
Stock and Other Ownership Interests - PAIGE.AI (Inst)
Patents, Royalties, Other Intellectual Property - Company Paige.AI MSK has licensed intellectual property related to digital pathology slides and algorithm development to Paige. MSK also holds equity in Paige. AI. (Inst)
 
Fionnuala Crowley
No Relationships to Disclose
 
Parima Saxena
No Relationships to Disclose
 
Amelia Chan
No Relationships to Disclose
 
Wungki Park
Honoraria - American Physician Institute; IntegrityCE
Consulting or Advisory Role - Astellas Pharma; Cerner Enviza; EXACT Therapeutics
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Break Through Cancer (Inst); Merck (Inst); Miracogen (Inst); NIH (Inst); NIH (Inst); Parker Institute for Cancer Immunotherapy (Inst); The Society of Memorial Sloan Kettering (Inst)
 
Anna M. Varghese
Consulting or Advisory Role - AstraZeneca (I); Lilly (I); PAIGE (I); Roche (I)
Research Funding - BioMed Valley Discoveries; Bristol-Myers Squibb; Illumina (I); Lilly; Silenseed; Verastem
Travel, Accommodations, Expenses - Roche (I)
 
Kenneth H. Yu
Employment - Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - Ipsen
Research Funding - General Oncology (Inst); Ipsen; OncoC4 (Inst); Senhwa Biosciences (Inst)
 
Marinela Capanu
No Relationships to Disclose
 
T. Peter Kingham
Honoraria - Olympus Medical Systems
Consulting or Advisory Role - Physicans' Education Resource
 
Michael Ian D'Angelica
No Relationships to Disclose
 
Vinod P. Balachandran
Research Funding - Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Inventors on a patent application related to work on antigen cross-reactivity and on a patent application related to work on neoantigen quality modeling.
 
William R. Jarnagin
No Relationships to Disclose
 
Alice C Wei
Consulting or Advisory Role - Histosonics
Research Funding - Ipsen (Inst)
Other Relationship - BioNTech SE (Inst); Clarity Pharmaceuticals (Inst); Epistem (Inst)
 
Kevin Soares
No Relationships to Disclose
 
Fiyinfolu Balogun
Honoraria - Mediflix (I); Varian Medical Systems (I)
Patents, Royalties, Other Intellectual Property - Mission Driven Tech. Brachytherapy (I)
 
Eileen M. O'Reilly
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Autem Medical (I); Berry Genomics (I); BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Eisai (I); Exelixis (I); Genentech/Roche (I); Ipsen; J-Pharma (I); Merck; Merus; Novartis; QED Therapeutics (I); SERVIER (I); Tempus; Vector Health (I); Yiviva (I)
Research Funding - Agenus (Inst); Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Bristol Myers Squibb (Inst); Digestive Care (Inst); Elicio Therapeutics (Inst); Genentech (Inst); Helsinn Healthcare (Inst); Parker Institute for Cancer Immunotherapy (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Yiviva (Inst)
(OPTIONAL) Uncompensated Relationships - Thetis Pharma